< David J Riley M.D. EOHSI Directory | EOHSI

David J Riley M.D. » EOHSI Directory

A B C D E F G H I J K L M N O P R S T U W Y Z

David J Riley M.D.

Rutgers, The State University of New JerseyEOHSI – Toxicology
Work Clinical Academic Building Suite 5200B 125 Paterson Street New Brunswick NJ 08901 Work Phone: 732-235-7840 Work Fax: 732-235-7048
Photo of David J Riley M.D.

Biographical Info

Research Areas
Clinical research in interstitial lung disease involving multi-center clinical trials. Two studies are ongoing in scleroderma interstitial lung disease and idiopathic pulmonary fibrosis. I also have an interest in the broad topic of acute lung injury, repair and pulmonary fibrosis in animal models and humans.

Research Highlights

  • Principal investigator on a multicenter NIH grant studying treatment of scleroderma interstitial lung disease therapy.
  • Principal investigator of clinical research study of treatment of idiopathic pulmonary fibrosis.

Scholarly Activities

  • Reviewer, “How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking Attributable Disease. A Report of the Surgeon General”,U.S.Department of Health and Human Services, Public Health Service, Office of the Surgeon General, Washington, 2010.
  • Reviewer, Special Emphasis Panel, CADET I: RFA-HL-11-015, NHLBI/NIH, 2010.
  • Member, United Peer Review Panel, American Heart Association, 2009 – 2012
  • Member, American Lung Association. Research Grant Review Committee Section B, 2008 – present.

Recent Publications

  1. Tashkin, DP, Roth, MD, Clements, PJ, Furst, DE, Khanna, D, Kleerup, EC, Goldin, J, Arriola, E, Volkmann, ER, Kafaja, S et al.. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016;4 (9):708-719. doi: 10.1016/S2213-2600(16)30152-7. PubMed PMID:27469583 PubMed Central PMC5014629
  2. Chang, YC, Sabourin, CL, Lu, SE, Sasaki, T, Svoboda, KK, Gordon, MK, Riley, DJ, Casillas, RP, Gerecke, DR. Upregulation of gamma-2 laminin-332 in the mouse ear vesicant wound model. J. Biochem. Mol. Toxicol. ;23 (3):172-84. doi: 10.1002/jbt.20275. PubMed PMID:19526566 PubMed Central PMC4465420
Search PubMed
Categories: Faculty
Updated 4 months ago.
Skip to toolbar